Deutsche Bank’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,076
| Closed | -$53.8K | – | 3655 |
|
|
2024
Q1 | $53.8K | Buy |
3,076
+2,137
| +228% | +$37.4K | ﹤0.01% | 3329 |
|
|
2023
Q4 | $14.7K | Hold |
939
| – | – | ﹤0.01% | 3455 |
|
|
2023
Q3 | $46.4K | Hold |
939
| – | – | ﹤0.01% | 3391 |
|
|
2023
Q2 | $73.4K | Buy |
939
+79
| +9% | +$6.18K | ﹤0.01% | 3375 |
|
|
2023
Q1 | $77.9K | Buy |
860
+218
| +34% | +$19.7K | ﹤0.01% | 3411 |
|
|
2022
Q4 | $75.8K | Buy |
642
+9
| +1% | +$1.06K | ﹤0.01% | 3427 |
|
|
2022
Q3 | $115K | Sell |
633
-126
| -17% | -$22.9K | ﹤0.01% | 3225 |
|
|
2022
Q2 | $69K | Sell |
759
-349
| -31% | -$31.7K | ﹤0.01% | 3630 |
|
|
2022
Q1 | $172K | Sell |
1,108
-39
| -3% | -$6.05K | ﹤0.01% | 3325 |
|
|
2021
Q4 | $342K | Sell |
1,147
-67
| -6% | -$20K | ﹤0.01% | 3050 |
|
|
2021
Q3 | $700K | Buy |
1,214
+133
| +12% | +$76.7K | ﹤0.01% | 2827 |
|
|
2021
Q2 | $491K | Sell |
1,081
-59
| -5% | -$26.8K | ﹤0.01% | 3213 |
|
|
2021
Q1 | $613K | Buy |
1,140
+329
| +41% | +$177K | ﹤0.01% | 2959 |
|
|
2020
Q4 | $717K | Buy |
811
+286
| +54% | +$253K | ﹤0.01% | 2653 |
|
|
2020
Q3 | $332K | Buy |
+525
| New | +$332K | ﹤0.01% | 2871 |
|